Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentral Prospective Study on Prediction of Malignant Progression of Oral Epithelial Dysplasia With p16 Hydroxymethylation

NCT02967120 is registered in ClinicalTrials.gov with Beijing Municipal Administration of Hospitals as lead sponsor.

NCT NCT02967120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02967120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentral Prospective Study on Prediction of Malignant Progression of Oral Epithelial Dysplasia With p16 Hydroxymethylation
Lead sponsor
Beijing Municipal Administration of Hospitals
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2014
Completion date
January 31, 2018
Enrollment
265 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oral epithelial dysplasia